Elbasvir – 5 mg

Brand:
Cayman
CAS:
1370468-36-2
Storage:
-20
UN-No:
Non-Hazardous - /

Elbasvir is a direct-acting antiviral drug that potently inhibits hepatitis C virus (HCV) non-structural protein 5A (NS5A) with an EC50 value of 2.2 pM in Huh7 human liver cancer cells expressing pH77S.3/GLuc2A, a cell-culture adapted HCV16 genotype 1a derivative and luciferase reporter, following a 48-hour exposure in vitro.{37386,37388} NS5A is essential for HCV RNA synthesis and viral assembly, and elbasvir inhibits the assembly of new viral replicase complexes when used at a concentration of 50 pM.{37388} It exhibits potent inhibitory activity against a broad range of HCV genotypes with EC50 values of 0.0002-34 nM in Huh7 cells expressing replicons of HCV genotype 4 NS5A and EC50 values of less than 0.2 nM for replicons from all other tested genotypes except 2b.{37385,37386,37387} Formulations containing elbasvir have been used alone and in combination with NS3/4A protease inhibitors in the treatment of HCV.  

 

Available on backorder

SKU: 24031 - 5 mg Category:

Description

A potent NS5A inhibitor (EC50 = 2.2 pM in Huh7 human liver cancer cells after 48 hours); inhibits the assembly of new viral replicase complexes (50 pM); exhibits activity against a broad range of HCV genotypes (EC50s = 0.0002-34 nM in Huh7 cells expressing HCV genotype 4 replicons of NS5A and EC50 = <0.2 nM for replicons from all other genotypes except 2b)


Formal name: N,N’-[[(6S)-6-phenyl-6H-indolo[1,2-c][1,3]benzoxazine-3,10-diyl]bis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-carbamic acid, C,C’-dimethyl ester

Synonyms:  MK-8742

Molecular weight: 882

CAS: 1370468-36-2

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Antivirals||Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|Hepatitis